Abstract
This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Antibodies / immunology
-
Antibodies / therapeutic use
-
Antigens, Neoplasm / immunology
-
Antigens, Neoplasm / therapeutic use
-
Cancer Vaccines / immunology
-
Cancer Vaccines / therapeutic use
-
Clinical Trials as Topic
-
Cytokines / immunology
-
Cytokines / therapeutic use
-
Female
-
Humans
-
Immunotherapy / methods*
-
Ovarian Neoplasms / immunology*
-
Ovarian Neoplasms / therapy*
-
Treatment Outcome
Substances
-
Antibodies
-
Antigens, Neoplasm
-
Cancer Vaccines
-
Cytokines